PEPstrMOD: Structure prediction of peptides containing natural, non-natural and modified residues

Biology Direct

Volumn 10, Issue 1, 2015, Pages

  Singh, Sandeep ^a   Singh, Harinder ^a   Tuknait, Abhishek ^a   Chaudhary, Kumardeep ^a   Singh, Balvinder ^a   Kumaran, S ^a   Raghava, Gajendra P S ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

Peptide modeling peptide prediction; Peptide structure of non natural residues; Peptide tertiary structure prediction

Indexed keywords

AMINO ACID; PEPTIDE;

CHEMISTRY; GENETICS; METABOLISM; PROCEDURES; PROTEIN DATABASE; PROTEIN PROCESSING; SEQUENCE ANALYSIS;

AMINO ACIDS; DATABASES, PROTEIN; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ANALYSIS, PROTEIN;

EID: 84955643299     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/s13062-015-0103-4     Document Type: Article

References (65)

1. Albericio F, Kruger HG. Therapeutic peptides. Future Med Chem. 2012;4(12):1527-31. doi: 10.4155/fmc.12.94.
2. Otvos L. Peptide-Based Drug Design Methods and Protocols. vol 494. Humana Press; 2008. doi: 10.1007/978-1-59745-419-3.
3. Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem Biol Drug Des. 2013;81(1):136-47. doi: 10.1111/cbdd.12055.
4. Stalmach A, Johnsson H, McInnes IB, Husi H, Klein J, Dakna M, et al. Identification of urinary peptide biomarkers associated with rheumatoid arthritis. PLoS One. 2014;9(8):e104625. doi: 10.1371/journal.pone.0104625.
5. Gautam A, Kapoor P, Chaudhary K, Kumar R, Raghava GP. Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics. Curr Med Chem. 2014;21(21):2367-91.
6. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Synthetic therapeutic peptides: science and market. Drug Discov Today. 2010;15(1-2):40-56. doi: 10.1016/j.drudis.2009.10.009.
7. Li ZJ, Cho CH. Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery. J Transl Med. 2012;10 Suppl 1:S1. doi: 10.1186/1479-5876-10-S1-S1.
8. Kaspar AA, Reichert JM. Future directions for peptide therapeutics development. Drug Discov Today. 2013;18(17-18):807-17. doi: 10.1016/j.drudis.2013.05.011.
9. Zhou H, Liu L, Huang J, Bernard D, Karatas H, Navarro A, et al. Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction. J Med Chem. 2013;56(3):1113-23. doi: 10.1021/jm3015298.
10. Takasaki W, Kajino Y, Kajino K, Murali R, Greene MI. Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor. Nat Biotechnol. 1997;15(12):1266-70. doi: 10.1038/nbt1197-1266.
11. Ishikawa K, Yue K, Dill KA. Predicting the structures of 18 peptides using Geocore. Protein Sci. 1999;8(4):716-21. doi: 10.1110/ps.8.4.716.
12. Kaur H, Garg A, Raghava GP. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept Lett. 2007;14(7):626-31.
13. Nicosia G, Stracquadanio G. Generalized pattern search algorithm for peptide structure prediction. Biophys J. 2008;95(10):4988-99. doi: 10.1529/biophysj.107.124016.
14. Thomas A, Deshayes S, Decaffmeyer M, Van Eyck MH, Charloteaux BB, Brasseur R. PepLook: an innovative in silico tool for determination of structure, polymorphism and stability of peptides. Adv Exp Med Biol. 2009;611:459-60.
15. Maupetit J, Derreumaux P, Tuffery P. A fast method for large-scale de novo peptide and miniprotein structure prediction. J Comput Chem. 2010;31(4):726-38. doi: 10.1002/jcc.21365.
16. Maupetit J, Derreumaux P, Tuffery P. PEP-FOLD: an online resource for de novo peptide structure prediction. Nucleic Acids Res. 2009;37(Web Server issue):W498-503. doi: 10.1093/nar/gkp323.
17. Narzisi G. NGaSG. Robust Bio-active Peptide Prediction Using Multi-objective Optimization. Biosciences (BIOSCIENCESWORLD), 2010 International Conference; 7-13 March 2010. Cancun: IEEE; 2010. p. 44-50.
18. Beaufays J, Lins L, Thomas A, Brasseur R. In silico predictions of 3D structures of linear and cyclic peptides with natural and non-proteinogenic residues. J Pept Sci. 2012;18(1):17-24. doi: 10.1002/psc.1410.
19. Thevenet P, Shen Y, Maupetit J, Guyon F, Derreumaux P, Tuffery P. PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res. 2012;40(Web Server issue):W288-93. doi: 10.1093/nar/gks419.
20. Yimin Shen JM. Philippe Derreumaux and Pierre Tuffery. Improved PEP-FOLD Approach for Peptide and Miniprotein Structure Prediction. J Chem Theory Comput. 2014. doi: 10.1021/ct500592m.
21. Thomas A, Deshayes S, Decaffmeyer M, Van Eyck MH, Charloteaux B, Brasseur R. Prediction of peptide structure: how far are we? Proteins. 2006;65(4):889-97. doi: 10.1002/prot.21151.
22. Agrawal P, Bhalla S, Usmani SS, Singh S, Chaudhary K, Raghava Gajendra PS et al. CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides. Nucleic Acids Research. 2015. doi: 10.1093/nar/gkv1266.
23. Kapoor P, Singh H, Gautam A, Chaudhary K, Kumar R, Raghava GP. TumorHoPe: a database of tumor homing peptides. PLoS One. 2012;7(4):e35187. doi: 10.1371/journal.pone.0035187.
24. Mehta D, Anand P, Kumar V, Joshi A, Mathur D, Singh S et al. ParaPep: a web resource for experimentally validated antiparasitic peptide sequences and their structures. Database (Oxford). 2014;2014. doi: 10.1093/database/bau051.
25. Gautam A, Chaudhary K, Singh S, Joshi A, Anand P, Tuknait A, et al. Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res. 2014;42(Database issue):D444-9. doi: 10.1093/nar/gkt1008.
26. Kumar R, Chaudhary K, Sharma M, Nagpal G, Chauhan JS, Singh S et al. AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides. Nucleic Acids Res. 2014. doi: 10.1093/nar/gku1141.
27. Tyagi A, Tuknait A, Anand P, Gupta S, Sharma M, Mathur D et al. CancerPPD: a database of anticancer peptides and proteins. Nucleic Acids Res. 2014. doi: 10.1093/nar/gku892.
28. Waghu FH, Gopi L, Barai RS, Ramteke P, Nizami B, Idicula-Thomas S. CAMP: Collection of sequences and structures of antimicrobial peptides. Nucleic Acids Res. 2014;42(Database issue):D1154-8. doi: 10.1093/nar/gkt1157.
29. Wynendaele E, Bronselaer A, Nielandt J, D'Hondt M, Stalmans S, Bracke N, et al. Quorumpeps database: chemical space, microbial origin and functionality of quorum sensing peptides. Nucleic Acids Res. 2013;41(Database issue):D655-9. doi: 10.1093/nar/gks1137.
30. Van Dorpe S, Bronselaer A, Nielandt J, Stalmans S, Wynendaele E, Audenaert K, et al. Brainpeps: the blood-brain barrier peptide database. Brain Struct Funct. 2012;217(3):687-718. doi: 10.1007/s00429-011-0375-0.
31. Singh S, Chaudhary K, Dhanda SK, Bhalla S, Usmani SS, Gautam A et al. SATPdb: a database of structurally annotated therapeutic peptides. Nucleic Acids Res. 2015. doi: 10.1093/nar/gkv1114.
32. Werle M, Bernkop-Schnurch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids. 2006;30(4):351-67. doi: 10.1007/s00726-005-0289-3.
33. Pollaro L, Heinis C. Strategies to prolong the plasma residence time of peptide drugs. Med Chem Comm. 2010;1(5):319-24. doi: 10.1039/c0md00111b.
34. Houde D, Peng Y, Berkowitz SA, Engen JR. Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol Cell Proteomics. 2010;9(8):1716-28. doi: 10.1074/mcp.M900540-MCP200.
35. Budisa N, Minks C, Medrano FJ, Lutz J, Huber R, Moroder L. Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V. Proc Natl Acad Sci U S A. 1998;95(2):455-9.
36. Gfeller D, Michielin O, Zoete V. SwissSidechain: a molecular and structural database of non-natural sidechains. Nucleic Acids Res. 2013;41(Database issue):D327-32. doi: 10.1093/nar/gks991.
37. Gfeller D, Michielin O, Zoete V. Expanding molecular modeling and design tools to non-natural sidechains. J Comput Chem. 2012;33(18):1525-35. doi: 10.1002/jcc.22982.
38. Zoete V, Cuendet MA, Grosdidier A, Michielin O. SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem. 2011;32(11):2359-68. doi: 10.1002/jcc.21816.
39. Khoury GA, Smadbeck J, Tamamis P, Vandris AC, Kieslich CA, Floudas CA. Forcefield_NCAA: Ab Initio Charge Parameters to Aid in the Discovery and Design of Therapeutic Proteins and Peptides with Unnatural Amino Acids and Their Application to Complement Inhibitors of the Compstatin Family. ACS Synth Biol. 2014. doi: 10.1021/sb400168u.
40. Khoury GA, Thompson JP, Smadbeck J, Kieslich CA, Floudas CA. Forcefield_PTM: charge and AMBER forcefield parameters for frequently occurring post-translational modifications. J Chem Theory Comput. 2013;9(12):5653-74. doi: 10.1021/ct400556v.
41. Petrov D, Margreitter C, Grandits M, Oostenbrink C, Zagrovic B. A systematic framework for molecular dynamics simulations of protein post-translational modifications. PLoS Comput Biol. 2013;9(7):e1003154. doi: 10.1371/journal.pcbi.1003154.
42. Margreitter C, Petrov D, Zagrovic B. Vienna-PTM web server: a toolkit for MD simulations of protein post-translational modifications. Nucleic Acids Res. 2013;41(Web Server issue):W422-6. doi: 10.1093/nar/gkt416.
43. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983;22(12):2577-637. doi: 10.1002/bip.360221211[doi].
44. Jones DT. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol. 1999;292(2):195-202. doi: 10.1006/jmbi.1999.3091.
45. Schrödinger L. The PyMOL Molecular Graphics System. 1.4.1 ed: Schrödinger, LLC.
46. Rose PW, Bi C, Bluhm WF, Christie CH, Dimitropoulos D, Dutta S, et al. The RCSB protein data bank: new resources for research and education. Nucleic Acids Res. 2013;41(Database issue):D475-82. doi: 10.1093/nar/gks1200.
47. O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: an open chemical toolbox. J Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.
48. Ramirez-Alvarado M, Blanco FJ, Niemann H, Serrano L. Role of beta-turn residues in beta-hairpin formation and stability in designed peptides. J Mol Biol. 1997;273(4):898-912. doi: 10.1006/jmbi.1997.1347.
49. Kaur H, Raghava GP. A neural network method for prediction of beta-turn types in proteins using evolutionary information. Bioinformatics. 2004;20(16):2751-8.
50. Hutchinson EG, Thornton JM. A revised set of potentials for beta-turn formation in proteins. Protein Sci. 1994;3(12):2207-16. doi: 10.1002/pro.5560031206.
51. Dunbrack Jr RL, Karplus M. Conformational analysis of the backbone-dependent rotamer preferences of protein sidechains. Nat Struct Biol. 1994;1(5):334-40.
52. Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J, Duke RE. AMBER 11. San Francisco: University of California; 2010.
53. Case DA, Cheatham 3rd TE, Darden T, Gohlke H, Luo R, Merz Jr KM, et al. The Amber biomolecular simulation programs. J Comput Chem. 2005;26(16):1668-88. doi: 10.1002/jcc.20290.
54. van der Spoel EL, B. Hess, and the GROMACS development team. GROMACS User Manual version 4.6.5. 2013.
55. Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comp. 2008;4(3):435-47. doi: 10.1021/ct700301q.
56. Hruby VJ, al-Obeidi F, Kazmierski W. Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations. Biochem J. 1990;268(2):249-62.
57. William L, Jorgensen JC, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926-35. doi: 10.1063/1.445869.
58. Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J. Interaction Models for Water in Relation to Protein Hydration. The Jerusalem Symposia on Quantum Chemistry and Biochemistry, vol 14. Netherlands: Springer; 1981.
59. Jmol. Jmol: an open-source Java viewer for chemical structures in 3D. http://www.jmol.org/.
60. Feig M, Karanicolas J, Brooks 3rd CL. MMTSB tool set: enhanced sampling and multiscale modeling methods for applications in structural biology. J Mol Graph Model. 2004;22(5):377-95. doi: 10.1016/j.jmgm.2003.12.005.
61. Clercq ED. Antivirals: current state of the art. Future Virol. 2008;3(4):393-405. doi: 10.2217/17460794.3.4.393.
62. Huther A, Dietrich U. The emergence of peptides as therapeutic drugs for the inhibition of HIV-1. AIDS Rev. 2007;9(4):208-17.
63. Rapsch K, Bier FF, von Nickisch-Rosenegk M. Rational design of artificial beta-strand-forming antimicrobial peptides with biocompatible properties. Mol Pharm. 2014;11(10):3492-502. doi: 10.1021/mp500271c.
64. Harrington JM, Scelsi C, Hartel A, Jones NG, Engstler M, Capewell P, et al. Novel African trypanocidal agents: membrane rigidifying peptides. PLoS One. 2012;7(9), e44384. doi: 10.1371/journal.pone.0044384.
65. Akhoon BA, Gupta SK, Verma V, Dhaliwal G, Srivastava M, Ahmad RF. In silico designing and optimization of anti-breast cancer antibody mimetic oligopeptide targeting HER-2 in women. J Mol Graph Model. 2010;28(7):664-9. doi: 10.1016/j.jmgm.2010.01.002.